AFP and hepatocellular carcinoma: The SALL4-specific T cell response was the strongest response, followed by MAGE-A3, NY-ESO-1, MAGE-A1 and SSX2, in patients with early-stage HCC, whereas the AFP-specific T cell response was the highest in patients with advanced-stage HCC.